Image For Activity Cover
High Impact Science: Novel Technologies and Approaches in Catheter Ablation
Description
This session will include five submissions considered as high impact science for presentation.
Learning Objectives
  • Recognize the potential role of ultra-low temperature cryoablation for treating ventricular arrhythmias.
  • Review re-ablation in post-PVI patients with isolated veins.
  • Describe the outcomes of PFA of the mitral isthmus.
Session Chair(s)
Benjamin Steinberg, MD, MHS
Nishaki Mehta, MD
Presentation
Impact of linear ablation in persistent AF on outcomes using a dual-energy, wide-footprint ablation catheter - Analysis from the SPHERE Per-AF Randomized Trial
Presenter(s): Moussa Mansour, MD, Tyler Louis. Taigen, MD, Dinesh Sharma, MD, MPH, Erich L. Kiehl, MD, MSci, Devi G. Nair, MD, Petr Neuzil, MD, PhD, Josef Kautzner, MD, PhD, Jose Osorio, MD, Andrea Natale, MD, Stavros Mountantonakis, MBA, MD, John D. Hummel, MD, Anish K. Amin, MD, Shephal K. Doshi, MD, Usman Siddiqui, MD, Jeffrey Cerkvenik, MS, Kelly A. van Bragt, MSci, PhD, Khaldoun G. Tarakji, MD, MPH, Elad Anter, MD, Vivek Y. Reddy, MD

Commentary: Impact of linear ablation in persistent AF on outcomes using a dual-energy, wide-footprint ablation catheter - Analysis from the SPHERE Per-AF Randomized Trial
Presenter(s): Thorsten Lewalter, PhD

Re-Ablation in Patients with Documented Isolated Veins Using a Tailored Approach Targeting Electrogram-Dispersion: The RESTART trial
Presenter(s): John D. Hummel, MD, Haroon Rachid, Isabel Deisenhofer, MD, Paul C. Zei, MD, PhD, Gustavo Morales, Jerome Horvilleur, Stavros Mountantonakis, MBA, MD, Jean-Paul Albenque, Devi G. Nair, MD, Benjamin D’Souza, Smit C. Vasaiwala, MD, Tom De Potter, Daniel H. Cooper, MD, Mark Metzl, Adi Lador, Anthony R. Magnano, MD, Alexandru B. Chicos, MD, Joshua R. Silverstein, MD, Daniel Guerrero, Shirley Beguin, Anas El-Benna, Sabine Lotteau, Marie-Sophie Nguyen-Tu, Paola MILPIED, PhD, Jerome Kalifa, MD, Bradley P. Knight, MD, Dhanunjaya R. Lakkireddy, MBA, MD

Commentary: Re-Ablation in Patients with Documented Isolated Veins Using a Tailored Approach Targeting Electrogram-Dispersion: The RESTART trial
Presenter(s): Jalaj Garg, MD

Initial Clinical Experience with the TactiFlex DUO System: Safety and Acute Results of the FOCALFLEX Study
Presenter(s): John Silberbauer, MA, MBBS, MD, Alan Bulava, MD, PhD, Prashanthan Sanders, MBBS, PhD, Jonathan M. Kalman, MBBS, PhD, Martin Martinek, MBA, MD, PhD, Isabel Deisenhofer, MD, Adrianus P. Wijnmaalen, MD, Martin Manninger, MD, PhD, Joaquin Osca, Eric E. Horvath, BS, MS, Daniel Scherr, MD

Commentary: Initial Clinical Experience with the TactiFlex DUO System: Safety and Acute Results of the FOCALFLEX Study
Presenter(s): Douglas Darden, MD

Pulsed-Field Ablation of The Mitral Isthmus: Transmurality and Autonomic Effects Validated with Vein of Marshall Recordings
Presenter(s): Apoor Patel, MD, Armen A. Kocharian, MD, Miguel Maturana Gonzalez, Miguel Valderrabano, MD, PhD

Commentary: Pulsed-Field Ablation of The Mitral Isthmus: Transmurality and Autonomic Effects Validated with Vein of Marshall Recordings
Presenter(s): Bharath Rajagopalan, MD

Novel ultra-low-temperature cryoablation system for ablation of ventricular arrhythmias: a multicenter experience
Presenter(s): Karl-Heinz Kuck, MD, FHRS, Julia Vogler, MD, Jan-Per Wenzel, Roman Mamaev, Sorin Stefan. Popescu, MD, Philipp Sommer, MD, Thomas Fink, MD, Rajdip Singh. Dulai, MBBS, Neil T. Srinivasan, MBChB, PhD, Magdi M. Saba, MD, MS, Anthony Li, BS, MBBS, MD, Tarvinder Dhanjal, MBChB, PhD, Rafaella Siang, Julian Kyoung-Ryul. Chun, MD, Boris Schmidt, MD, Anja Schade, Thomas Deneke, MD, PhD, Christopher Kowalewski, MD, Charlotte Eitel

Commentary: Novel ultra-low-temperature cryoablation system for ablation of ventricular arrhythmias : a multicenter experience
Presenter(s): Smit C. Vasaiwala, MD
Disclosures
Moussa Mansour:
  • Boston Scientific (Honoraria/Speaking/Consulting Fee - Consulting)
  • KODEX -EPD (Stock Options – Privately Held (including start-up companies) - Consulting)
  • NewPace Ltd (Stock Options – Privately Held (including start-up companies) - Consulting)
  • Biosense Webster, Inc. (Honoraria/Speaking/Consulting Fee - Consulting)
  • Medtronic,Inc. (Honoraria/Speaking/Consulting Fee - Consulting)
  • Siemens (Honoraria/Speaking/Consulting Fee - Consulting)
  • Abbott (Honoraria/Speaking/Consulting Fee - Consulting)
Thorsten Lewalter:
  • Biotronik (Speakers' Bureau - Board Membership)
  • Medtronic,Inc. (Honoraria/Speaking/Consulting Fee - Board Membership)
  • Daiichi Sankyo (Honoraria/Speaking/Consulting Fee - Speaking and Teaching)
  • Boston Scientific (Honoraria/Speaking/Consulting Fee - Speaking and Teaching)
  • Bayer Healthcare Pharmaceuticals (Honoraria/Speaking/Consulting Fee - Speaking and Teaching)
  • Abiomed (Honoraria/Speaking/Consulting Fee - Speaking and Teaching)
  • Pfizer/BMS (Honoraria/Speaking/Consulting Fee - Speaking and Teaching)
John Hummel:
  • Volta Medical (Honoraria/Speaking/Consulting Fee - Speaking and Teaching)
  • Medtronic (Honoraria/Speaking/Consulting Fee - Consulting)
  • Abbott (Research (Contracted Grants for PIs and Named Investigators only) - Consulting)
Jalaj Garg:
  • Nothing Relevant to Disclose
Daniel Scherr:
  • Nothing Relevant to Disclose
Douglas Darden:
  • Nothing Relevant to Disclose
Apoor Patel:
  • Biosense Webster, Inc. (Research (Contracted Grants for PIs and Named Investigators only) - Research)
  • Boston Scientific (Honoraria/Speaking/Consulting Fee - Consulting)
Bharath Rajagopalan:
  • Nothing Relevant to Disclose
Roland Tilz:
  • Medtronic (Travel/Entertainment - Research)
  • Biosense Webster, Inc. (Honoraria/Speaking/Consulting Fee - Speaking and Teaching)
  • Abbott Medical (Honoraria/Speaking/Consulting Fee - Speaking and Teaching)
Smit Vasaiwala:
  • Volta Medical (Honoraria/Speaking/Consulting Fee - Research)
  • Biosense Webster, Inc. (Honoraria/Speaking/Consulting Fee - Consulting)
  • Abbott Medical (Speakers' Bureau - Speaking and Teaching)

To view all Heart Rhythm 2025 Faculty Disclosures, please click here.
Education Framework
Ventricular Tachyarrhythmias
   --   Ventricular Tachycardia (VT) - Catheter Ablation
      --   184. Know the indications, contraindications, and complications associated with catheter ablation of ventricular arrhythmias, including endocardial and epicardial ablation, including during pregnancy.
Summary
Availability: No future session
Cost: FREE
Credit Offered:
No Credit Offered
Recommended
  Heart Rhythm Society
1325 G Street NW, Suite 500
Washington, DC 20005
P: 202-464-3400 F: 202-464-3401
E: questions@heartrhythm365.org
© Heart Rhythm Society
Privacy Policy | Cookie Declaration | Linking Policy | Patient Education Disclaimer | State Nonprofit Disclosures | FAQ
 
Android App Download IOS App Download Powered By